Main description:

Proteomics: A Promising Approach for Cancer Research provides an updated overview of scientific knowledge, achievements and findings in the field of cancer proteomics. The book discusses topics such as the use of proteomics in cancer biology and drug discovery, its role in surgical oncology, applications of mass spectrometry, target proteomics, single-cell proteomics, and next-generation proteomics. In addition, it discusses proteomics and phosphor-proteomics in cancer precision medicine; translation of proteomics research into clinical application; and challenges and future developments of the field. This will be a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment.

The field of cancer proteomics is very dynamic, with emerging trends related to clinical solutions developed in recent years, therefore this book's content helps readers get up-to-speed on the topic to easily apply learnings into their research or clinical practice.

Contents:

1. Cancer proteomics: An overview
2. Proteomics: A groundbreaking development in cancer biology
3. Proteomics: Landmark advancements and challenges in cancer biomarker and drug discovery
4. Proteomic profiling and its applications in cancer research
5. Role of Proteomics in surgical oncology
6. Applications of Mass spectrometry in understanding cancer proteomics
7. Proteomics: A modern tool for identifying therapeutic targets in different type of carcinomas
8. Cancer proteomics: Application of case studies in diverse cancers
9. A shift from Shotgun proteomic to Targeted proteomics: A step forward in cancer research
10. Applications of proteomics in cancer diagnosis
11. Single-cell proteomics: Role in cancer immunotherapy
12. Applications of Next-Generation Proteomics in cancer research
13. Data-Independent acquisition: Application in cancer proteomics
14. Applications of plasma membrane proteomics in the discovery of cancer biomarkers
15. Cancer proteomic assay development: A hypothesis-driven approach
16. Utility of Proteomics and phospho-proteomics in the tailored medication of cancer
17. Translation of proteomic research into clinical application for cancer treatment
18. Cancer proteomics: current status, challenges, and future outlook